RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - NUOVI BERSAGLI PER LA PREVENZIONE E LA CURA DELLA ATROFIA MUSCOLARE IN CORSO DI NEOPLASIA
• 2 - Caratterizzazione dei meccanismi molecolari e cellulari della sarcopenia.
• 3 - Dalla rigenerazione alla ricostruzione del muscolo scheletrico: meccanismi regolatori e applicazioni terapeutiche
• 4 - Meccanismi di regolazione della plasticità del muscolo scheletrico
• 5 - Meccanismi molecolari funzionali nella patogenesi delle miopatie primitive: verso nuovi approcci prognostici e terapeutici
• 6 - Meccanismi cellulari e molecolari coinvolti nel rimodellamento muscolare indotto da elettrostimolazione in soggetti giovani ed anziani.
• 7 - Genomica funzionale e modulazione dell'espressione delle proteine di membrana nelle miopatie primitive
• 8 - Analisi funzionale di reti geniche coinvolte nella risposta del muscolo scheletrico agli stimoli differenziativi, meccanici e di stress
• 9 - Le vie di segnale Akt-FoxO e calcineurina-NFAT come bersaglio per la terapia delle distrofie muscolari
• 10 - APPROCCI MOLECOLARI E FARMACOLOGICI PER LA CORREZIONE DELL'IPERCATABOLISMO PROTEICO MUSCOLARE NELLA CACHESSIA NEOPLASTICA

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze agrarie e veterinarie
  • PATOLOGIA GENERALE E ANATOMIA PATOLOGICA VETERINARIA
  • CLINICA CHIRURGICA VETERINARIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Campania

Bibliografia

1.Wojcik S, Engel WK, McFerrin J, Askanas V. Myostatin is increased and complexes with amyloid-b within sporadic inclusion-body myositis muscle fibers. Acta Neuropathol. 2005 110: 173–177.
2.Paciello O, Wójcik S, Engel W K, McFerrin J, Askanas V. Parkin and its association with a-synuclein and Abeta;PP in inclusion-body myositis and A?PP-overexpressing cultured human muscle fibers. American Journal of Pathology 2006, in press.
3.Paciello O, Shelton GD, Papparella S. Muscle fibers in canine masticatory muscle Myositis express Major Histocompatibility Complex class I and II independently of cellular infiltration. Neuromuscular Disorders 2006, in press.
4.Paciello O, Pasolini MP, Navas L, Russo V, Papparella S. Myopathy with Central Cores in a Foal Vet Pathol. 2006; 46: in press.
5.Paciello O, Maiolino P, Fatone G, Papparella S. Mitochondrial myopathy in a german shepherd dog. Vet Pathol. 2003 Sep;40(5):507-11.
6.Engel WK, Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases. Arch Neurol. 1970 Feb;22(2):97-117.
7.Mendell JR, Engel WK. The fine structure of type II muscle fiber atrophy Neurology. 1971 Apr;21(4):358-65.
8.Pleasure DE, Walsh GO, Engel WK. Atrophy of skeletal muscle in patients with Cushing's syndrome Arch Neurol. 1970 Feb;22(2):118-25.
9.Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol. 2004 Oct;287(4):C834-43.
10.Carlson CJ, Booth FW, and Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol Regul Integr Comp Physiol 277: R601–R606, 1999.
11.Lalani R, Bhasin S, Byhower F, Tarnuzzer R, Grant M, Shen R, Asa S, Ezzat S, and Gonzalez-Cadavid NF. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 167: 417–428, 2000.
12.Sharma M, Langley B, Bass J, and Kambadur R. Myostatin in muscle growth and repair. Exerc Sport Sci Rev 29: 155–158, 2001.
13.Lee, S.J. and McPherron, A.C. (2001) Proc. Natl. Acad. Sci. U.S.A. 98, 9306–9311
14.Wolfman, N.M., McPherron, A.C., Pappano, W.N., Davies, M.V., Song, K., Tomkinson, K.N., Wright, J.F., Zhao, L., Sebald, S.M., Greenspan, D.S. et al. (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 15842–15846
15.Hill, J.J., Davies, M.V., Pearson, A.A., Wang, J.H., Hewick, R.M., Wolfman, N.M. and Qiu, Y. (2002) J. Biol. Chem. 277, 40735–40741.
16.Hill, J.J., Qiu, Y., Hewick, R.M. and Wolfman, N.M. (2003) Mol. Endocrinol. 17, 1144–1154.
17.Scott, I.C., Blitz, I.L., Pappano, W.N., Imamura, Y., Clark, T.G., Steiglitz, B.M., Thomas, C.L., Maas, S.A., Takahara, K., Cho, K.W. et al. (1999) Dev. Biol. 213, 283–300.
18.McPherron AC, Lawler AM, Lee S-J. 1997. Regulation of skeletal muscle mass in mice by a new TGF-b; superfamily member. Nature 387:83–90.
19.Philip, B., Lu, Z. and Gao, Y. (2005) Cell. Signalling 17, 365–375.
20.Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B. and Cabello, G. (2003) Exp. Cell Res. 286, 263–275.
21.Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S. and Kambadur, R. (2002) J. Biol. Chem. 277, 49831–49840.
22.Grobet, L., Poncelet, D., Royo, L.J., Brouwers, B., Pirottin, D., Michaux, C.,Menissier, F., Zanotti, M., Dunner, S. and Georges, M. (1998) Mamm. Genome 9, 210–213.
23.Carlson CJ, Booth FW, and Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol Regul Integr Comp Physiol 277: R601–R606, 1999.
24.Lalani R, Bhasin S, Byhower F, Tarnuzzer R, Grant M, Shen R, Asa S, Ezzat S, and Gonzalez-Cadavid NF. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 167: 417–428, 2000.
25. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, and Salehian B. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285: E363–E371, 2003.
26.Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, and Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA 95: 14938–14943, 1998.
27.Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, and Khurana TS. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418–421, 2002.
28.Bogdanovich, S., Perkins, K.J., Krag, T.O., Whittemore, L.A. and Khurana, T.S. (2005) FASEB J. 19, 543–549
29.Patel, K. and Amthor, H. (2005) Neuromuscular Disord. 15, 117–126.
30.Li, Z.F., Shelton, G.D. and Engvall, E. (2005) Am. J. Pathol. 166, 491–497
31.Zimmers, T.A., Davies, M.V., Koniaris, L.G., Haynes, P., Esquela, A.F., Tomkinson, K.N., McPherron, A.C., Wolfman, N.M. and Lee, S.J. (2002) Science 296, 1486–1488
32.Reisz-Porszasz, S., Bhasin, S., Artaza, J.N., Shen, R., Sinha-Hikim, I., Hogue, A., Fielder, T.J. and Gonzalez-Cadavid, N.F. (2003) Am. J. Physiol. Endocrinol. Metab. 285, E876–E888.
33.Gamer LW, Wolfman NM, Celeste AJ, Hattersley G, Hewick R, Rosen V. 1999. A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev. Biol. 208:222–32.
34.Nakashima M, Toyono T, Akamine A, Joyner A. 1999. Expression of growth/differentiation factor 11, a new member of the BMP/TGF-b; superfamily during mouse embryogenesis. Mech. Dev. 80:185–89.
35.Campion D. 1984. The muscle satellite cell: a review. Intl. Rev. Cytol. 87:225–51.
36.Bischoff R. 1994. The satellite cell and muscle regeneration. In Myology: Basic and Clinical, ed.AEngel,CFranzini-Armstrong, pp. 97–118. New York: McGraw-Hill.
37.McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. 2003. Myostatin negatively regulates satellite cell activation and selfrenewal. J. Cell Biol. 162:1135–47.
38.Zimmers TA, DaviesMV, Koniaris LG, Haynes P, Esquela AF, et al. 2002. Induction of cachexia in mice by systemically administered myostatin. Science 296:1486–88.
39.Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, et al. 2001. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 280:E221–28.
40.Hepple RT. 2003. Sarcopenia—a critical perspective. Sci. Aging Knowl. Environ. 2003: p31–37.
41.Wagner KR, McPherron AC, Winik N, Lee SJ. 2002. Loss of myostatin attenuates severità of muscular dystrophy in mdx mice. Ann. Neurol. 52:832–36.
42.Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. 1989. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578–80.
43.Tisdale MJ. 1999. Wasting in cancer. J. Nutr. 129:243S–46S.
44.Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA. 2002. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys.Res. Commun. 291:701–6.
45.McPherron AC, Lee S-J. 2002. Suppression of body fat accumulation in myostatin-deficient mice. J. Clin. Invest. 109:595–601.

Parole Chiave

MIOSTATINA, MUSCOLO, ATROFIA, DEBOLEZZA, INIBITORI DELLA MIOSTATINA, CANE